Skip to Content
scroll

Cochlear Ltd (COH) $304.74

We discussed COH earlier in the week after it was downgraded to a “Sell” by UBS who made some interesting points around the potential for Moderna getting a vaccine approved to treat ~20% of child deafness.

  • We see limited upside in COH until some clarity is delivered on Moderna’s mRNA-1547 drug – COH reports on the 19th of this month
COH
MM are neutral towards COH
Add To Hit List
chart
image description
Cochlear Ltd (COH)
image description

Relevant suggested news and content from the site

Back to top